CD274 and neoplasm: In the present study, CM could significantly reduce the tumor growth rate in the early tumor stage, enhance the response to immunosuppressant PD-L1 inhibitor, exert a synergistic effect, and enhance the effect of the PD-L1 inhibitor attacking the tumor.